Center for Studies of Host Response to Cancer Therapy
Project Number5P20GM109005-10
Contact PI/Project LeaderBOERMA, MARJAN
Awardee OrganizationUNIV OF ARKANSAS FOR MED SCIS
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
The objectives of the Center for Studies of Host Response to Cancer Therapy are to (1) form a self-sustaining
multidisciplinary research center within the University of Arkansas for Medical Sciences (UAMS) to increase the
understanding of mechanisms of side effects of cancer therapy, identify methods for early detection, and develop
strategies to prevent or treat such side effects and (2) help junior investigators with research programs in this
common theme establish themselves as independent scientists. Achieving these goals will create a vibrant,
multidisciplinary yet synergistic research environment. To our knowledge, few research centers focus on cancer
survivorship, and none take the paradigm-shifting approach of proactively addressing treatment-related toxicities
to improve overall cancer treatment outcomes. Specifically, this Center will provide an environment for young
investigators to succeed as independent scientists (Aim 1); strengthen the overall research infrastructure at
UAMS and the Winthrop P. Rockefeller Cancer Institute (Aim 2); and ensure that the Center becomes self-
sustaining (Aim 3). All 6 project leaders recruited to the Center in Phase 1 have built well-funded, productive
research programs and close collaborations with each other and several of the pilot project grantees. In
preparation for Phase 2, we have recruited 4 promising new/early-stage independent investigators. During Phase
1, the Center focused heavily on radiation therapy. To increase the impact and scope of the Center while
retaining its overall theme, project leaders recruited for Phase 2 have a research focus on both radiation and
chemotherapy. To increase the likelihood that project leaders will successfully secure independent extramural
research funding, individualized mentoring and faculty-development plans will be implemented, and support from
an administrative core and 2 research service cores will be integral. To replace project leaders who achieve
independence and graduate from COBRE support, a pipeline of new project leaders is ensured through
institutional support for recruiting junior faculty combined with a structured pilot project program. Strengthening
our interactions with the 5 other COBRE Centers and additional NIH-supported programs that enhance
biomedical research on the UAMS and affiliated campuses will also contribute to establishing the Center as a
self-sustaining research program that is well-integrated in the institution. The Center's progress will be guided
by highly qualified External and Internal Advisory Committees. Strong institutional support combined with active
interest from funding agencies in improving uncomplicated cancer cure rates and the quality of life of cancer
survivors ensures a high likelihood of success for the Center for Studies of Host Response to Cancer Therapy.
Public Health Relevance Statement
PROJECT NARRATIVE
Many cancer patients and survivors suffer from adverse effects of treatment that can present during and after
the completion of cancer therapy. The COBRE Center for Studies of Host Response to Cancer Therapy brings
together and supports investigators from various disciplines who perform research to understand mechanisms
by which cancer therapy causes adverse effects; identify new methods for early detection of side effects; and
develop novel strategies to reduce these side effects. The overall goal is to build a self-sustaining research
center that aids in making cancer treatment safer and maximize the number of uncomplicated cancer cures.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdverse effectsAdvisory CommitteesAffectAftercareAnimalsApplications GrantsArkansasAwardBiologicalBiomedical ResearchCancer DetectionCancer PatientCancer SurvivorCancer SurvivorshipCenters of Research ExcellenceChemotherapy and/or radiationChronicClinicalCollaborationsDedicationsDevelopmentDevelopment PlansDisciplineDose LimitingEarly DiagnosisEnsureEnvironmentExtramural ActivitiesFacultyFee-for-Service PlansFundingFunding AgencyGoalsImmune responseImmune systemIndividualInstitutionInterdisciplinary StudyLifeMalignant NeoplasmsMedicalMentorsMethodsOncologyPediatric HospitalsPhasePilot ProjectsPredispositionPreparationProcessProductivityQualifyingQuality of lifeRadiationRadiation therapyResearchResearch InfrastructureResearch InstituteResearch PersonnelResearch Project GrantsResearch SupportResourcesRoleScienceScientistSecureServicesStructureTeacher Professional DevelopmentTherapeuticTissuesToxicologyTranslational ResearchTreatment EfficacyTreatment outcomeTreatment-Related CancerTreatment-related toxicityUnited States National Institutes of HealthUniversitiesanti-cancer treatmentbasecancer therapycareerchemotherapycomparativedisabilityeffective interventionimprovedinterestmultidisciplinarynovel strategiespreventprogramspsychosocialquality of life for cancer survivorsrecruitresponseside effectsuccesssynergismtherapy adverse effecttranslational approachtumor
No Sub Projects information available for 5P20GM109005-10
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P20GM109005-10
Patents
No Patents information available for 5P20GM109005-10
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P20GM109005-10
Clinical Studies
No Clinical Studies information available for 5P20GM109005-10
News and More
Related News Releases
No news release information available for 5P20GM109005-10
History
No Historical information available for 5P20GM109005-10
Similar Projects
No Similar Projects information available for 5P20GM109005-10